United States · FDA National Drug Code directory
Fluticasone propionate and Salmeterol
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69097-662_6a4f271b-bc4d-4e04-b5d2-d8e8a48d7215
- Product NDC
- 69097-662
- Form
- POWDER
- Composition / generic term
- Fluticasone propionate and Salmeterol
- Labeler
- Cipla USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260727
- Source listing expiry
- 20271231
Source-listed ingredients
- FLUTICASONE PROPIONATE — 100 ug/1
- SALMETEROL XINAFOATE — 50 ug/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 INHALER in 1 CARTON (69097-662-03) / 60 POWDER in 1 INHALER · 69097-662-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →